News

Genomics Outlook Trends, Share, Forecast, Overview and Analysis by 2028

September 6, 2021

The global genomics outlook is expected to reach a market size of 56.54 Billion by 2028 and register a double-digit CAGR over the forecast period, according to latest analysis by Emergen Research. The steady projected growth can be attributed to technological innovations in the field of genomics. The report provides detailed insights into genomics outlook trends, industry trends, consumer trends, market size, market share, market revenue growth, and forecast, along with ranging impact of each factor and driver. Mergers and acquisitions between key players in the field is another key factor driving market growth. Increasing research on cancer, usage of genomic systems among academics and government institutions, and decreasing cost of sequencing is contributing significantly to growth in cancer diagnostics. It also provides analysis of various factors expected to restrain or limit potential growth in genomics outlook size over the forecast period, 2020–2028. The Tumor Genomics report includes profiles of major players in the market, strategies being employed, mergers, acquisitions, recent developments, agreements, contracts, new product development and launches, segment revenue, investment details as well as financials.

Download FREE Sample PDF Copy (Customized Sample PDF File delivered as per your specific requirement)@ https://www.emergenresearch.com/request-sample/531

Tumor is often caused by genetic alterations, including gene fusions, large chromosomal rearrangements; however, next generation sequencing techniques have helped researchers gather vast amounts of tumor genomic data and record genetic mutations in various cancer types. Varying market trends can be attributed to inclining revenue growth of the global genomics outlook going ahead. genomics outlook trends include rising focus by major players on product/service expansion into new and untapped domestic markets and rising competition. Other positive genomics outlook trends include rising demand and deployment in respective sectors/industries in major and developing countries. In addition, implementation of favorable government policies, advancements in technology, and steady economic growth across various regions and countries are factors expected to continue to result in further genomics outlook trend evolution and changes going ahead.

In addition, rapidly rising demand and deployment in respective sectors/industries in major and developing countries is supporting growth in terms of genomics outlook share contribution of these countries. In addition, genomics outlook share contribution is expected to continue to incline steadily over the forecast period due to favorable government policies, advancements in technology, and steady economic growth across various regions and countries.

Access the Entire Report packed with TOC, Tables and Figures and Outline of Prominent Companies@ https://www.emergenresearch.com/industry-report/tumor-genomics-market

In terms of genomics outlook share and revenue contribution to the global genomics outlook, North America is expected to maintain its dominance over other regional markets over the forecast period. Presence of major companies in countries in the region is a key factor supporting rapid increase in genomics outlook share.

The market intelligence report on the Tumor Genomics Industry also includes an extensive investigation of the competitive landscape. It assesses the business and marketing strategies expected to be present in the market through the forecast years. It also includes an investigation of the recent advancements and other factors driving the growth of the overall market to help comprehend the progress of the companies in the coming years.

Key Highlights of Report

In September 2018, Cancer Genetics Inc. and NovellusDx Ltd. signed a merger agreement in order to combine their data associated to tumor anatomy. The aim behind the merger is to enhance and accelerate the therapeutic development to improve treatment success rates for companies. With the proprietary technology and machine learning technology of NovellusDX Ltd., Cancer Genetics aims to form a leading oncology-focused precision medicine company.
Biomarkers play an important role in the detection of cancer and it may be used to detect early cancer symptoms or to perform differential diagnosis of cancerous tumors.
Revenue from the tumor genomic market in Asia Pacific is expected to expand at a rapid CAGR during the forecast period. This can be attributed to rising government funding for cancer detection and awareness, and introduction of state-of-the-art research institutions.
Key players in genomic biomarkers are Thermo Fisher Scientific Inc., Illumina, Inc., QIAGEN, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Pacific Biosciences of California, Inc., NeoGenomics Laboratories, Inc., Myriad Genetics, Inc., and PerkinElmer.

Read Trending news@ Investor Welcome

Region wise performance of the Tumor Genomics industry

North America genomics outlook trend scenario has significant impact on other regional market trends. North America genomics outlook accounted for largest revenue share in 2020 and is expected to continue to maintain its dominance over other regional markets over the forecast period. Presence of major players in countries in the region is a key factor driving steady change in overall genomics outlook trends.

Asia Pacific genomics outlook is expected to register comparatively faster revenue growth than other regional markets over the forecast period. This can be attributed to varying genomics outlook trend scenarios in countries such as China, India, South Korea, and others. These scenarios with regard to domestic market trends and international market trends and varying impacts play a major role in growth of the Asia Pacific market.

Asia Pacific market share contribution to the global genomics outlook is expected to continue to register comparatively faster growth rate than other regional markets between 2020 and 2028. Increasing population, favorable government policies and initiatives, rising disposable income among consumers in countries in the region, influence of genomics outlook trends in other countries and regions, and steady economic growth are some key factors driving market revenue growth of the Asia Pacific genomics outlook.

Europe genomics outlook size and revenue growth is primarily supported by genomics outlook trends such as continuous developments in major countries in the region, robust focus on research and development initiatives by major firms, and changing market trends in countries in other major regions.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:

United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:

North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

Fill up the Form to get exciting Discount on this Tumor Genomics Report@ https://www.emergenresearch.com/request-discount/531

The research provides answers to the following key questions:

What will be the growth rate and the market size of the Tumor Genomics industry for the forecast period 2020-2027?
What are the major driving forces expected to impact the development of the genomics outlook across different regions?
Who are the major driving forces expected to decide the fate of the Tumor Genomics industry worldwide?
Who are the prominent market players making a mark in the genomics outlook with their winning strategies?
Which Tumor Genomics industry trends are likely to shape the future of the industry during the forecast period 2020-2027?
What are the key barriers and threats believed to hinder the development of the industry?
What are the future opportunities in the genomics outlook?

Why Choose Emergen Research?